PRIMARY BREAST LYMPHOMA

This adverse event was reported 16 times

These drugs are most commonly taken by patients reporting PRIMARY BREAST LYMPHOMA:

# Drug Count
0 METHOTREXATE SODIUM 4
1 ADALIMUMAB 3
2 INFLIXIMAB 3
3 INSULIN GLARGINE 3
4 ALENDRONATE SODIUM 2
5 ALENDRONATE SODIUM TABLET 2
6 FOLIC ACID 2
7 INSULIN GLARGINE-YFGN 2
8 OMEPRAZOLE 2
9 OMEPRAZOLE MAGNESIUM 2
See all common drugs associated with PRIMARY BREAST LYMPHOMA

PRIMARY BREAST LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NELARABINE 1 0.0010
1 INFLIXIMAB-DYYB 1 0.0003
2 ALENDRONATE SODIUM TABLET 2 0.0001
3 INSULIN GLARGINE-YFGN 2 0.0001
4 PEGFILGRASTIM 1 0.0001
5 VALSARTAN AND HYDROCHLOROTHIAZIDE 1 0.0001
6 MERCAPTOPURINE 1 0.0001
7 INSULIN DEGLUDEC 1 0.0000
8 FILGRASTIM 1 0.0000
9 GUSELKUMAB 1 0.0000
See all drugs enriched for association with PRIMARY BREAST LYMPHOMA

PRIMARY BREAST LYMPHOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
1 Folate Analog [EPC] 1 0.0000
2 Vitamin A [EPC] 1 0.0000
3 Interleukin-23 Antagonist [EPC] 2 0.0000
4 Nicotinic Acid [EPC] 1 0.0000
5 Antidote [EPC] 1 0.0000
6 Topoisomerase Inhibitor [EPC] 1 0.0000
7 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
8 Janus Kinase Inhibitor [EPC] 2 0.0000
9 Prostaglandin Analog [EPC] 1 0.0000
See all drug classes enriched for association with PRIMARY BREAST LYMPHOMA